WHC is still in active development. Read this to understand our approach.
depiction of BWPIARFWQZKAIA-UHFFFAOYSA-N.svg
isomerdesign

Protriptyline

Verificar en isomerdesign

pubchem

Protriptyline

Verificar en pubchem

drugmap

Protriptyline

Verificar en drugmap

wiki

Protriptyline

Verificar en wiki

Data

InChI: InChI=1S/C19H21N/c1-20-14-6-11-19-17-9-4-2-7-15(17)12-13-16-8-3-5-10-18(16)19/h2-5,7-10,12-13,19-20H,6,11,14H2,1H3

Sinónimos: 3-(5H-Dibenzo[a,d]cyclohepten-5-yl)-N-methyl-1-propanamine,Lopac-P-8813,BDBM50176062, Triptil,PROTRIPTYLINE [VANDF], Protriptyline (INN),5H-Dibenzo[a,d]cycloheptene-5-propylamine, N-methyl-,NCGC00015851-07,BRD-K42098891-003-03-1,PROTRIPTYLINE [INN],5-(3-Methylaminopropyl)-5H-Dibenzo[a,d]cycloheptene,NCGC00015851-15,HSDB 3391, Triadapin 5, Maximed,Protriptilina,Protriptyline,Vivactyl,NCGC00015851-05, Novopramine, N-Methyl-5H-dibenzo(a,d)cycloheptene-5-propylamine,4NDU154T12, Protriptylinum [INN-Latin], Triptyl,N-Methyl-5H-dibenzo[a,d]cycloheptene-5-propanamine,NCGC00015851-04, Triptil hydrochloride,MK 240,Prestwick0_000930,AB00489964, N-Methyl-5H-dibenzo[a,d]cycloheptene-5-propanamine,PROTRIPTYLINE [HSDB],BPBio1_000924,Protriptylinum,3-(11H-dibenzo[1,2-a:1',2'-e][7]annulen-11-yl)-N-methylpropan-1-amine,NCGC00024439-03,PROTRIPTYLINE [WHO-DD], Apo-Trimip, Normethyl EX4442,Vivactil,Protriptylinum [INN-Latin],D08447,AB00489964_10, Vivactil (TN),protriptyline,Protriptyline (INN), Protriptylinum,UNII-4NDU154T12,methyl(3-{tricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-2-yl}propyl)amine,methyl(3-{tricyclo[9.4.0.0,3,8]pentadeca-1(15),3,5,7,9,11,13-heptaen-2-yl}propyl)amine,NCGC00015851-02,L000913,Protriptyline [INN:BAN],Vivactil (Salt/Mix),Prestwick3_000930,5H-Dibenzo(a,d)cycloheptene-5-propanamine, N-methyl-, hydrochloride,Amimetilina,3-(5H-dibenzo[a,d][7]annulen-5-yl)-N-methylpropan-1-amine,CAS-1225-55-4,Prestwick2_000930, Apo-Imipramine,NSC169912,NCGC00015851-01,CS-0013761,SPBio_003019,Protryptyline, Vivactil, Novo-Doxepin,GTPL7285, Vivactyl,7-(3-Methylaminopropyl)-1,2:5,6-dibenzocycloheptatriene,Concordin (Salt/Mix),DTXSID0023535,DB00344, Impril,AKOS015962184,PDSP1_001390,AC-15971,SCHEMBL34267, Novo-Tripramine,Triptil,NCGC00015851-03,438-60-8,Q408432,HY-B0949A, 5H-Dibenzo[a, d]cycloheptene-5-propanamine, N-methyl-, hydrochloride, N-Methyl-5H-dibenzo[a,d]cycloheptene-5-propylamine, Rhotrimine, 7-(3-Methylaminopropyl)-1,2:5,6-dibenzocycloheptatriene,BRN 2217411,CHEMBL668, Protriptyline [INN:BAN], 3-(5H-Dibenzo[a,d]cyclohepten-5-yl)-N-methyl-1-propanamine,BIDD:PXR0157,PROTRYPTYLINE HYDROCHLORIDE, 3-(5H-dibenzo[a,d][7]annulen-5-yl)-N-methylpropan-1-amine,N-Methyl-5H-dibenzo[a,d]cycloheptene-5-propylamine, Protryptyline, N-3-(5H-Dibenzo(a,d)cyclohepten-5-yl)propyl-N-methylamine,NCGC00015851-06,BSPBio_000840,EINECS 207-119-9,3-(11H-dibenzo[[?],[?]][7]annulen-11-yl)-N-methyl-propan-1-amine,SBI-0050947.P002,Protriptilina [INN-Spanish], 5-(3-Methylaminopropyl)-5H-dibenzo(a,d)cycloheptene,MK-240,ZINC1530764,EN300-18552820, Protriptilina [INN-Spanish],5H-Dibenzo(a,d)cycloheptene-5-propylamine, N-methyl-,CCG-205054,5-(3-Methylaminopropyl)-5H-dibenzo(a,d)cycloheptene, 5-(3-Methylaminopropyl)-5H-Dibenzo[a,d]cycloheptene,SDCCGSBI-0050947.P003,Prestwick1_000930,5H-Dibenzo[a, d]cycloheptene-5-propanamine, N-methyl-, hydrochloride, Protriptilina,CHEBI:8597,PROTRIPTYLINE [MI],N-Methyl-5H-dibenzo(a,d)cycloheptene-5-propylamine,N-3-(5H-Dibenzo(a,d)cyclohepten-5-yl)propyl-N-methylamine,5H-Dibenzo[a,d]cycloheptene-5-propanamine, N-methyl-,Lopac0_000974,PDSP2_001374,C07408,5H-Dibenzo(a,d)cycloheptene-5-propanamine, N-methyl-,N-methyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenyl)propan-1-amine,3-(5H-Dibenzo[a,d]cyclohepten-5-yl)-N-methyl-1-propanamine #


Estimated data

Solubilidad: -3.668 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 36.4% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.